From Data to Decisions: Powering Growth in MedTech
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “From Data to Decisions: Powering Growth in MedTech” inside PodZeus.
In this episode of MedTech Gurus, host Tom Hickey welcomes Mike Monavoukas, CEO and co-founder of AcuityMD, to discuss how AI-powered data platforms are transforming medical device commercialization. Monavoukas shares his journey from a failed medtech startup to building AcuityMD, a platform that uses a specialized ontology and AI to help innovators identify the right physicians, patients, and markets with precision. The conversation highlights the critical gap between clinical innovation and commercial success, emphasizing that founders must integrate market access, health economics, and commercial strategy from day one. The episode underscores the importance of data-driven go-to-market strategies, especially for underserved populations like veterans and rural communities, and explores how AI can democratize innovation by empowering clinicians and healthcare systems to become active participants in product development. Monavoukas also previews AcuityMD’s future focus on de-risking early-stage innovation through AI tools. Key takeaways include: 1) Founders must prioritize transformative, high-impact innovations over incremental improvements to stand out in today’s crowded market; 2) Market access and health economic strategy should be developed in parallel with product development, not after FDA approval; 3) AI and real-world data can level the playing field for new entrants by democratizing insights traditionally held by established players; 4) Underserved patient populations, such as veterans and rural patients, represent significant untapped opportunities; 5) The future of medtech lies in democratizing innovation by enabling clinicians and health systems to contribute ideas and de-risk concepts early in the pipeline.
Focus on transformative innovations, not incremental 'Me Too' products, to capture investor attention and break through market noise.
Integrate market access, health economics, and commercial strategy from the earliest stages of product development.
Leverage AI and real-world data to identify high-potential physicians, patients, and markets with precision.
Underserved populations like veterans and rural patients represent major growth opportunities often overlooked by traditional sales models.
Empower clinicians and healthcare systems as innovators by providing tools to de-risk and prototype new medical technology ideas.
The Power of Disruptive Innovation in MedTech
“If I were giving one piece of advice for founders, it would be to keep thinking about those massive disruptive opportunities that can shape medicine if they're executed on. Because those are the ones that are going to get attention. Those are the ones that are going to get investment dollars and these incremental Me Too products and improvements. They just can't break through the noise anymore.”
From Failed Startup to AI-Powered Commercialization
Monavoukas recounts his first medtech startup experience with the Wound Stylus, where he realized the power of deep market research and data synthesis. This insight led to the creation of AcuityMD, a platform that uses AI and a specialized medtech ontology to democratize access to market intelligence.
AcuityMD's Unique MedTech Ontology and AI Features
The platform’s core innovation lies in its medtech-specific ontology that models complex relationships between physicians, facilities, and procedures. AI-driven features like automated call plans help sales reps prepare effectively, turning data into actionable insights.
Case Study: Scaling AlphaStim for Veterans
“They were able to take a data-driven approach to executing on this new commercial strategy using data to guide their team's actions and then focusing time and resources around the most impactful activities as opposed to a pound-the-pavement approach.”
Debunking Myths and Embracing the New Sales Reality
“You have to think about your go-to-market strategy in concert with your regulatory and clinical strategy from the very beginning.”
“If I were giving one piece of advice for founders, it would be to keep thinking about those massive disruptive opportunities that can shape medicine if they're executed on. Because those are the ones that are going to get attention. Those are the ones that are going to get investment dollars and these incremental Me Too products and improvements. They just can't break through the noise anymore.”
“What if we can unleash all of them as innovators? What if there is a way to massively expand the market for how these new product concepts originate and de-risk how they go to market over time.”
“The analogy in med tech would be you've got, you know, so many people, you know, surgeons, clinicians, you know, who observe... what's going on in the operating room... What if we can unleash all of them as innovators?”
Hosts
Guest
Mike Monavoukas
person
AcuityMD
organization
Tom Hickey
person
MedTech Gurus
media
EPI
organization
Sylvester Harris
person
VA Patient Population
other
AlphaStim
other
FDA
other
Wound Stylus
other
Stickers That Can Save Lives: The Future of MicroWearable Health Monitoring
Med Tech Gurus • 40m • 4/8/2026
Beating the Clock: Rethinking Brain Tumor Care
Med Tech Gurus • 31m • 4/15/2026
From Acute Care to Continuous Care
Med Tech Gurus • 40m • 4/22/2026
When Every Minute Is Critical: Scaling AI to Save Stroke Patients
Med Tech Gurus • 40m • 5/6/2026
The Product Adoption Lie: Why Great MedTech Fails to Scale
Med Tech Gurus • 43m • 5/13/2026
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “From Data to Decisions: Powering Growth in MedTech” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime